CEREVANCE
LIVE

Serial Number

98830357

Owner

Cerevance, Inc.

Attorney

Hara K. Jacobs

Filing Date

Oct 31, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CEREVANCE Trademark

Serial Number: 98830357

CEREVANCE is a trademark filed by Cerevance, Inc. on October 31, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Cerevance, Inc. (4 trademarks)

One Marina Park Drive
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

October 31, 2024

Registration Date

Not Registered

Published for Opposition

February 3, 2026

Goods & Services

Medical and pharmacological research services; Drug discovery services; Pharmaceutical drug development services; Scientific investigations and research for medical purposes; Research and development of vaccines and medicines; Analysis of human tissues for scientific and medical research purposes; Design and development of medical diagnostic apparatus and software applications; Providing online non-downloadable software for use in medical and pharmacological research; Software as a service (SaaS) featuring software for use in medical and pharmacological research; Providing online non-downloadable software for use in drug discovery; Software as a service (SaaS) featuring software for use in drug discovery; Providing online non-downloadable software for use in delivering drugs; Software as a service (SaaS) featuring software for use in delivering drugs; Consultancy, information and advisory services relating to all the afore-mentioned services

Downloadable software for performing medical and pharmacological research; Downloadable software applications for performing medical and pharmacological research; Downloadable software for performing drug discovery research; Downloadable software applications for performing drug discovery research; Downloadable software for use in delivering drugs; Downloadable software applications for use in delivering drugs

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceuticals for the treatment of obesity; Pharmaceuticals for the treatment of central nervous system diseases and disorders; Drug delivery agents in the form of injectable solutions, powders, tablets, capsules, coatings for tablets and edible wafers that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Filing History

EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 5, 2026 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 28, 2025 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 19, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 19, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 19, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 19, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 25, 2025 GNFN
FINAL REFUSAL E-MAILED
Aug 25, 2025 GNFR
FINAL REFUSAL WRITTEN
Aug 25, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 7, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 7, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2025 NWOS
NEW APPLICATION ENTERED
Oct 31, 2024 NWAP